Copyright
©2012 Baishideng Publishing Group Co.
World J Virol . Feb 12, 2012; 1(1): 23-30
Published online Feb 12, 2012. doi: 10.5501/wjv.v1.i1.23
Published online Feb 12, 2012. doi: 10.5501/wjv.v1.i1.23
Vaccine1 | Pigs2 | Route | Dose (mL) | Program |
Ingelvac PRRS MLV | Gilt/Sow | im | 2 | At any stage of production3 |
Piglet/Nursery/Growing | im | 2 | At any stage of production3 | |
ReproCyc PRRS-PLE | Gilt/Sow | im | 5 | Primary: 4-6 wk prior to breeding |
Booster: prior to subsequent breeding | ||||
Ingelvac PRRS ATP | Nursery/Growing | im | 2 | At 3-18 wk of age |
Porcilis PRRS | Gilt/Sow | im/id | 2/0.2 | Primary: 2-4 wk prior to breeding |
Booster: 2-4 wk prior to subsequent breeding/or every 4 mo | ||||
At 2 wk of age or older | ||||
Piglet/Nursery/Growing | im/id | 2/0.2 | ||
Amervac-PRRS | Nursery/Growing | im | 2 | At 4 wk of age or older |
Pyrsvac-183 | Gilt/Sow | im | 2 | Primary: 2-4 wk prior to breeding |
Booster: 3-4 wk prior to subsequent breeding | ||||
Piglet/Nursery/Growing | im | 2 | At 2-3 wk of age or older |
- Citation: Charerntantanakul W. Porcine reproductive and respiratory syndrome virus vaccines: Immunogenicity, efficacy and safety aspects. World J Virol 2012; 1(1): 23-30
- URL: https://www.wjgnet.com/2220-3249/full/v1/i1/23.htm
- DOI: https://dx.doi.org/10.5501/wjv.v1.i1.23